Company Profile

Augnition Labs LLC
Profile last edited on: 9/29/23      CAGE: -----      UEI: HZ3VDKZRFQJ9

Business Identifier: AI-powered digital assessment and monitoring solutions for early detection of cognitive decline.
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

515 Madison Avenue Floor 29
New York, NY 10022
   (917) 697-2310
   info@augnitionlabs.com
   www.augnitionlabs.com
Location: Single
Congr. District: 12
County: New York

Public Profile

With the underlying science informed by over 15 years of research more than 50 peer-reviewed publications, Augmem™ uses neural circuit-based approaches backed by proprietary AI to create highly sensitive digital cognitive assessment tools. The firm's approach is anchored in decades of computational and empirical research across species that has now reliably demonstrated that memory for everyday events requires a process known as “pattern separation”. This process allows the human brain to create unique memories for similar experiences -- for example, where you parked your car today vs. yesterday -- enabling us also to store and retain rich, detailed memories of our past. As we all get older, we begin to struggle with pattern separation, leading to a loss of contextual memories (where certain events occurred or when they occurred). Most of these changes can be benign and part of the normal aging process. Individuals affected by Alzheimer’s disease struggle to a much greater extent. Work by the Augniiton team has shown that loss of pattern separation can be an early marker of memory loss in Alzheimer’s disease, prior to the onset of clinical symptoms. Augmem™ is a digital cognitive assessment platform targeting pattern separation, coupled with an artificial intelligence (AI) engine that generates unprecedented insights into the cognitive processes and brain systems that underlie memory loss. It is highly sensitive to even the most subtle shifts in cognition and has been extensively validated using brain imagi

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,965,523
Project Title: Augmem: a Novel Digital Cognitive Assessment for the Early Detection of Alzheimer's Disease

Key People / Management

  Andrew Anderson -- Principal Technical Advisor

  Adele Gilpin -- Co-Founder and Chief Regulatory Officer

  Ali Kennedy Scott -- Head of Corporate Development and Strategy

  Marco Peters -- Co-Founder and Scientific Advisor

  Laurence Unger -- Director of Finance

  Michael Yassa -- Co-Founder and Chief Scientific Advisor

Company News

There are no news available.